Evidence map›Paper›PMID 42909258›Full record

ArticleOpen forum infectious diseases2026

Characterization of an Unusual Severe Yellow Fever Outbreak in the Colombian Andean Region.

Alex Julián Forero-Delgadillo, Jeison Andrés Morales-Olivera, Paula O Narvaez-Ramirez, Natalia Sanabria-Herrera, Valeria Aguirre Gutierrez, Lina F Martinez-Lemus, Cristian C Serrano-Mayorga, Diana Catalina Ramírez-Reyes, Juan Diego Melo-Pedraza, Julián Celis-Guzmán and 8 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Alex Julián Forero-DelgadilloUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0003-2924-5151
Jeison Andrés Morales-OliveraUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0002-4076-9127
Paula O Narvaez-RamirezUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0001-9099-646X
Natalia Sanabria-HerreraUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0009-0003-3790-4740
Valeria Aguirre GutierrezUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0009-0003-5846-8781
Lina F Martinez-LemusUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0009-0007-4295-168X
Cristian C Serrano-MayorgaUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0001-8344-0535
Diana Catalina Ramírez-ReyesClinical and Translational Medicine Research Group, Critical Physiology Subdivision, Intensive Care Department, Hospital Federico Lleras Acosta, Ibagué, Colombia.
Juan Diego Melo-PedrazaClinical and Translational Medicine Research Group, Critical Physiology Subdivision, Intensive Care Department, Hospital Federico Lleras Acosta, Ibagué, Colombia.ORCID https://orcid.org/0009-0005-7631-2283
Julián Celis-GuzmánClinical and Translational Medicine Research Group, Critical Physiology Subdivision, Intensive Care Department, Hospital Federico Lleras Acosta, Ibagué, Colombia.ORCID https://orcid.org/0000-0002-5793-4803
Gustavo González-VaronaClinical and Translational Medicine Research Group, Critical Physiology Subdivision, Intensive Care Department, Hospital Federico Lleras Acosta, Ibagué, Colombia.ORCID https://orcid.org/0009-0002-1968-5145
Henry Robayo-AmorteguiDoctorado en Ciencias Clínicas, Facultad de Medicina, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0003-4613-1703
Jessica María ForeroDepartment of Pediatric Nephrology, Fundación Valle del Lili, Cali, Colombia.ORCID https://orcid.org/0000-0002-6526-757X
Erwin HernandezUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0002-7189-5863
Ingrid G BustosUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0002-6540-2815
Sara DuqueISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-6616-8354
Esteban Garcia-GalloISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-8030-9985
Luis F ReyesUnisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0003-1172-6539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Yellow fever (YF) reemerged in Colombia's Andean region during 2024-2025, outside the country's historically recognized endemic areas. We characterized critically ill adults admitted during this outbreak and described clinical features, organ dysfunction, supportive care, and in-hospital outcomes. Methods: We conducted a prospective observational cohort study of consecutive adults with reverse transcription polymerase chain reaction (RT-PCR)-confirmed YF admitted to the national referral intensive care unit in Ibagué, Tolima, Colombia, from March through September 2025. Clinical, laboratory, complication, intervention, and outcome data were prospectively captured using a standardized case report form. Results: Sixty-one patients were analyzed; 22 died (36.1%). Non-survivors had lower platelet counts and fibrinogen and higher INR, aminotransferases, lactate dehydrogenase, and creatinine at ICU admission. Shock, acute kidney injury, acute respiratory distress syndrome, disseminated intravascular coagulation, and severe bleeding were more frequent among non-survivors. Prior YF vaccination was self-reported by 10 patients (16.4%). Conclusions: Severe YF in this Andean outbreak was characterized by hepatic-coagulation abnormalities and multisystem organ dysfunction. The occurrence of critical illness outside historically recognized endemic areas supports surveillance and vaccination strategies that can adapt to changing epidemiological risk.

Indexed as

Colombiacritical illnessintensive careoutbreakyellow fever

Identifiers

PMID42909258
PMCPMC13684397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.